News
INM’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a loss of -11.06%.However, over the last six months, we can see a stronger performance of -46.61%. Over the last 30 days, the price of INM has fallen by 10.12%. And in the last five days, it has surged by 5.71%. InMed Pharmaceuticals Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $2.08 on 10/24/23,
